Aclarion Inc (ACON) - Total Assets
Based on the latest financial reports, Aclarion Inc (ACON) holds total assets worth $13.20 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ACON debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Aclarion Inc - Total Assets Trend (2019–2024)
This chart illustrates how Aclarion Inc's total assets have evolved over time, based on quarterly financial data. See what is Aclarion Inc's book value for net asset value and shareholders' equity analysis.
Aclarion Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Aclarion Inc's total assets of $13.20 Million consist of 38.8% current assets and 61.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 21.4% |
| Accounts Receivable | $18.33K | 0.9% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.29 Million | 60.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Aclarion Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Aclarion Inc market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aclarion Inc's current assets represent 38.8% of total assets in 2024, an increase from 15.3% in 2019.
- Cash Position: Cash and equivalents constituted 21.4% of total assets in 2024, up from 9.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, a decrease from 81.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 60.9% of total assets.
Aclarion Inc Competitors by Total Assets
Key competitors of Aclarion Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
NIGHTINGALE HEALTH EO 1
F:7XE
|
Germany | €67.04 Million |
|
Trivarx Ltd
AU:TRI
|
Australia | AU$24.33 Million |
|
Principal Technologies Inc
V:PTEC
|
Canada | CA$870.31K |
|
Medadvisor Ltd
AU:MDR
|
Australia | AU$39.84 Million |
|
CodeLab Capital A/S
OL:CODE
|
Norway | Nkr58.82 Million |
|
Kovo Healthtech Corp
V:KOVO
|
Canada | CA$6.64 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$533.91 Million |
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
Aclarion Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 17.01 | 2.80 | 0.01 |
| Quick Ratio | 17.01 | 2.79 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $11.20 Million | $1.22 Million | $-8.28 Million |
Aclarion Inc - Advanced Valuation Insights
This section examines the relationship between Aclarion Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.28 |
| Latest Market Cap to Assets Ratio | 0.72 |
| Asset Growth Rate (YoY) | -13.7% |
| Total Assets | $2.12 Million |
| Market Capitalization | $1.53 Million USD |
Valuation Analysis
Below Book Valuation: The market values Aclarion Inc's assets below their book value (0.72x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Aclarion Inc's assets decreased by 13.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Aclarion Inc (2019–2024)
The table below shows the annual total assets of Aclarion Inc from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.12 Million | -13.67% |
| 2023-12-31 | $2.46 Million | -15.61% |
| 2022-12-31 | $2.91 Million | +54.26% |
| 2021-12-31 | $1.89 Million | +46.27% |
| 2020-12-31 | $1.29 Million | -9.69% |
| 2019-12-31 | $1.43 Million | -- |
About Aclarion Inc
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom softwa… Read more